Literature DB >> 6660845

Relationships between chemical structures of 8-aminoquinolines and their capacities for radical cure of infections with Plasmodium cynomolgi in rhesus monkeys.

L H Schmidt.   

Abstract

Evaluation of 200 8-aminoquinolines for the capacities to effect radical cure of infections with sporozoites of Plasmodium cynomolgi in rhesus monkeys led to identification of 34 derivatives with activity equal or superior to that of primaquine and to characterization of substituents on the quinoline nucleus and side chain that favored or prejudiced curative activity. Of the 34 derivatives, 19 were as active as primaquine, 9 were twice as active, and 6 were four times as active. With respect to nuclear substituents, all were methoxy substituted at position 6; 24 had one and 10 had two additional substituents. The additions with most favorable impact on activity included methyl substituents at positions 4 and 2 and alkoxy, fluoro, and a group of 3- or 4-substituted phenoxy substituents at position 5. With respect to 8-amino substituents, 14 of the 15 derivatives more active than primaquine, and 13 of the 19 as active as primaquine, carried a branched alkyl chain, four to five carbons in length, between the 8- and terminal amino groups. Proximity of branching to the 8-amino group could be an important determinant of curative activity; however, the effect of such branching was not predictable. All 15 derivatives more active than primaquine and a substantial fraction of those comparable to primaquine in activity have sufficient structural novelty to merit evaluation for tolerability and radical curative activity in humans, with reasonable prospects that one or more would be better tolerated than primaquine and superior to this drug for cure of Plasmodium vivax infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6660845      PMCID: PMC185911          DOI: 10.1128/AAC.24.5.615

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Metabolism of pentaquine in the rhesus monkey.

Authors:  C C SMITH
Journal:  J Pharmacol Exp Ther       Date:  1956-01       Impact factor: 4.030

2.  Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily.

Authors:  R JONES; L S JACKSON; A DI LORENZO; R L MARX; B L LEVY; E C KENNY; M GILBERT; M N JOHNSTON; A S ALVING
Journal:  Am J Trop Med Hyg       Date:  1953-11       Impact factor: 2.345

3.  THE CLINICAL TRIAL OF EIGHTEEN ANALOGUES OF PAMAQUIN (PLASMOCHIN) IN VIV AX MALARIA (CHESSON STRAIN).

Authors:  A S Alving; T N Pullman; B Craige; R Jones; C M Whorton; L Eichelberger
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

4.  Metabolites of pamaquine in urine.

Authors:  B B BRODIE; S UDENFRIEND
Journal:  Proc Soc Exp Biol Med       Date:  1950-08

5.  Metabolism of various 8-aminoquinolines in rhesus monkey.

Authors:  H B BUGHES; L H SCHMIDT
Journal:  Proc Soc Exp Biol Med       Date:  1950-04

6.  Malaria imported to the United States from Vietnam. Chemoprophylaxis evaluated in returning soldiers.

Authors:  O Barrett; G Skrzypek; W Datel; J D Goldstein
Journal:  Am J Trop Med Hyg       Date:  1969-07       Impact factor: 2.345

7.  Plasmodium cynomolgi infections in the rhesus monkey.

Authors:  L H Schmidt
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

8.  Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report.

Authors:  J H EDGCOMB; J ARNOLD; E H YOUNT; A S ALVING; L EICHELBERGER; G M JEFFERY; D EYLES; M D YOUNG
Journal:  J Natl Malar Soc       Date:  1950-12

9.  COMPARISON OF CHLOROQUINE, QUINACRINE (ATABRINE), AND QUININE IN THE TREATMENT OF ACUTE ATTACKS OF SPOROZOITE-INDUCED VIV AX MALARIA (CHESSON STRAIN).

Authors:  T N Pullman; B Craige; A S Alving; C M Whorton; R Jones; L Eichelberger
Journal:  J Clin Invest       Date:  1948-05       Impact factor: 14.808

10.  The problem of vivax malaria in Vietnam returnees. II. Malaria chemoprophylaxis survey.

Authors:  G Skrzypek; O Barrett
Journal:  Mil Med       Date:  1968-06       Impact factor: 1.437

View more
  17 in total

1.  Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3β of substituted quinolines.

Authors:  Jianyu Lu; Izumi Maezawa; Sahani Weerasekara; Ramazan Erenler; Tuyen D T Nguyen; James Nguyen; Luxi Z Swisher; Jun Li; Lee-Way Jin; Alok Ranjan; Sanjay K Srivastava; Duy H Hua
Journal:  Bioorg Med Chem Lett       Date:  2014-06-04       Impact factor: 2.823

2.  Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.

Authors:  M J Portela; R Moreira; E Valente; L Constantino; J Iley; J Pinto; R Rosa; P Cravo; V E do Rosário
Journal:  Pharm Res       Date:  1999-06       Impact factor: 4.200

Review 3.  Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.

Authors:  Brice Campo; Omar Vandal; David L Wesche; Jeremy N Burrows
Journal:  Pathog Glob Health       Date:  2015-04-18       Impact factor: 2.894

4.  Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.

Authors:  L H Schmidt; R N Rossan
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

Review 5.  Antimalarial drug discovery - approaches and progress towards new medicines.

Authors:  Erika L Flannery; Arnab K Chatterjee; Elizabeth A Winzeler
Journal:  Nat Rev Microbiol       Date:  2013-11-11       Impact factor: 60.633

6.  Toxicity in rhesus monkeys following administration of the 8-aminoquinoline 8-[(4-amino-l-methylbutyl)amino]- 5-(l-hexyloxy)-6-methoxy-4-methylquinoline (WR242511).

Authors:  Gary Rockwood; Steven Duniho; Crystal Briscoe; Mark Gold; Kevin Armstrong; David Kahler; Anita Moran; Steven Baskin
Journal:  J Med Toxicol       Date:  2008-09

7.  Screening procedure using chicks infected with the sporozoites of Plasmodium gallinaceum in an antimalarial drug development programme.

Authors:  K E Kinnamon; D E Davidson; D S Rane
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Antimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol.

Authors:  L H Schmidt; R N Rossan; R Fradkin; R Sullivan; W Schulemann; L Kratz
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

9.  Imidazoquines as antimalarial and antipneumocystis agents.

Authors:  Nuno Vale; Miguel Prudêncio; Catarina A Marques; Margaret S Collins; Jiri Gut; Fátima Nogueira; Joana Matos; Philip J Rosenthal; Melanie T Cushion; Virgílio E do Rosário; Maria M Mota; Rui Moreira; Paula Gomes
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.